BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7252164)

  • 1. Detection of immune complexes using a solid-phase C1q polystyrene ball assay.
    Pohl DA; Tsai CC; Roodman ST
    J Immunol Methods; 1981; 40(3):313-30. PubMed ID: 7252164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of C1q-bearing immune complexes by a monoclonal anti-C1q ELISA system.
    Antes U; Heinz HP; Loos M
    J Immunol Methods; 1987 Sep; 102(2):149-56. PubMed ID: 2443573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid-phase Clq-binding fluorescence immunoassay for detection of circulating immune complexes.
    Collins MM; Casavant CH; Stites DP
    J Clin Microbiol; 1982 Mar; 15(3):456-64. PubMed ID: 6804486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the C1q solid-phase binding assay for immune complexes. A clinical and laboratory study.
    Scullion M; Balint G; Whaley K
    J Clin Lab Immunol; 1979 Apr; 2(1):15-22. PubMed ID: 95801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The development of a C1q-solid-phase immunoenzyme method for determining circulating immune complexes].
    Nedugova GI
    Zh Mikrobiol Epidemiol Immunobiol; 1991 Jun; (6):56-9. PubMed ID: 1716037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A solid-phase radioimmunoassay for C1q-binding immune complexes. I. Delta IgG as indicator molecule.
    Svehag SE
    Scand J Immunol; 1975; 4(7):687-97. PubMed ID: 1198070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of IgG aggregates or immune complexes using solid-phase C1q and protein A-rich Staphylococcus aureus as an indicator system.
    Farrell C; Sogaard H; Svehag SE
    Scand J Immunol; 1975; 4(7):673-80. PubMed ID: 1198069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating immune complexes in Lyme arthritis. Detection by the 125I-C1q binding, C1q solid phase, and Raji cell assays.
    Hardin JA; Walker LC; Steere AC; Trumble TC; Tung KS; Williams RC; Ruddy S; Malawista SE
    J Clin Invest; 1979 Mar; 63(3):468-77. PubMed ID: 429566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for the presence of autoantibodies to the collagen-like portion of C1q in systemic lupus erythematosus.
    Antes U; Heinz HP; Loos M
    Arthritis Rheum; 1988 Apr; 31(4):457-64. PubMed ID: 3258749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on circulating soluble immune complexes of the liver disease. 6. Comparative studies of 125I-pRF inhibition assay, 125I-Clq inhibition assay and 125I-Clq binding assay.
    Narumoto J
    Gastroenterol Jpn; 1981; 16(2):174-85. PubMed ID: 6971771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between renal pathology and the size of circulating immune complexes in patients with systemic lupus erythematosus.
    Wener MH; Mannik M; Schwartz MM; Lewis EJ
    Medicine (Baltimore); 1987 Mar; 66(2):85-97. PubMed ID: 3102894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection and partial characterization of immune complexes in patients with rheumatoid arthritis plus Sjogren's syndrome and with Sjogren's syndrome alone.
    Yoshinoya S; McDuffy S; Alarcon-Segovia D; Pope RM
    Clin Exp Immunol; 1982 May; 48(2):339-47. PubMed ID: 6980743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1q solid-phase radioimmunoassay: binding properties of solid-phase C1q and evidence that C1q-binding IgG complexes in systemic lupus erythematosus are not bound to endogenous C1q.
    Uwatoko S; Aotsuka S; Okawa M; Egusa Y; Yokohari R; Aizawa C; Suzuki K
    J Immunol Methods; 1984 Oct; 73(1):67-74. PubMed ID: 6436382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of immune-complex size and antigen-antibody ratio on immune complex detection with monoclonal rheumatoid factor and C1q.
    Vanham G; Bloemmen FJ; Ceuppens JL; Stevens EA
    J Clin Lab Immunol; 1984 Oct; 15(2):63-8. PubMed ID: 6335179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to the collagen-like region of C1q in sera of patients with autoimmune rheumatic diseases.
    Wener MH; Uwatoko S; Mannik M
    Arthritis Rheum; 1989 May; 32(5):544-51. PubMed ID: 2785797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of soluble immune complexes to Raji lymphocytes. Role of receptors for complement components, C1q and C3-C3b.
    Gupta RC; McDuffie FC; Tappeiner G; Jordon RE
    Immunology; 1978 Apr; 34(4):751-61. PubMed ID: 102587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune complexes in rheumatoid arthritis sera and synovial fluids: a comparison of three methods.
    Halla JT; Volanakis JE; Schrohenloher RE
    Arthritis Rheum; 1979 May; 22(5):440-8. PubMed ID: 444313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q.
    Nydegger UE; Lambert PH; Gerber H; Miescher PA
    J Clin Invest; 1974 Aug; 54(2):297-309. PubMed ID: 4847246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porcine C1q and the solid-phase immunoassay of human immune complexes.
    Ziola B; Salmi A; Penttinen K
    J Immunol Methods; 1982 Mar; 49(3):247-60. PubMed ID: 6978362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of activation of C1, despite circulating immune complexes detected by two C1q methods, in patients with rheumatoid arthritis.
    Hack CE; Eerenberg-Belmer AJ; Lim UG; Haverman J; Aalberse RC
    Arthritis Rheum; 1984 Jan; 27(1):40-8. PubMed ID: 6318777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.